Interactions may exist between commonly used immunosuppressants and SGLT2 inhibitors, however, the view is that potential interactions are overall modest and unlikely to result in hypoglycemia or compromise immunosuppression [34]. Here, SLC5A2 is linked to Hypoglycemia.